PRL and hyperprolactinemia: Even though normalization of PRL concentrations by DA therapy can improve BMD and can reduce the risk of fracture, it may be necessary to treat specifically osteoporosis with the same therapeutic options as in the general population in addition to the treatment for hyperprolactinemia.